Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion

Kamoru Ademola Adedokun

doi:10.1186/s40779-021-00316-5

Your Location：

Home >

Browse articles >

Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion

LETTER TO THE EDITOR | Updated：2023-02-28

- Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
- Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
- 解放军医学杂志（英文版） 2021年8卷第4期页码：584-586
- Affiliations：
  
  Oral Pathology Unit, Dental University Hospital, King Saud University Medical City, Riyadh 11545, Saudi Arabia
- Author bio：
  
  adeolokun@yahoo.com
- Funds：
- DOI：10.1186/s40779-021-00316-5
  中图分类号：
- 纸质出版：2021-12
- Accepted：
Scan QR Code
Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion[J]. 解放军医学杂志（英文版）, 2021,8(4):584-586.

Adedokun: Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion. Mil Med Res,2021, 8: 22.
Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion[J]. 解放军医学杂志（英文版）, 2021,8(4):584-586. DOI： 10.1186/s40779-021-00316-5.

Adedokun: Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion. Mil Med Res,2021, 8: 22. DOI： 10.1186/s40779-021-00316-5.

摘要

Abstract

Evidence shows that pulmonary problems in coronavirus disease 2019 (COVID-19) may set off from vascular injury that progresses to physiological disturbances through a compromised gas exchange

following an infection with the severe acute respiratory syndrome coronavirus 2. In this process

inefficient gas exchange in the alveolar could precipitate silent nonclinical hypoxemia. Unfortunately

patients with "silent hypoxemia" do not necessarily experience any breathing difficulty (dyspnea) at the early stage of COVID-19 while the disease progresses. As a result

several asymptomatic

presymptomatic and patients with mild symptoms may escape quarantine measure and thus continue to spread the virus through contacts. Therefore

early diagnosis of "silent hypoxemia "

which attracts no clinical warnings

could be an important diagnostic measure to prevent acute respiratory distress syndrome from the risk of pulmonary failure among the presymptomatic and as a screening tool in the asymptomatic who are hitherto potential spreaders of the virus.

关键词

Keywords

references

Marini JJ , Gattinoni L . Management of COVID-19 respiratory distress . JAMA . 2020 ; 323 ( 22 ): 2329 - 30 . https://doi.org/10.1001/jama.2020.6825 https://doi.org/10.1001/jama.2020.6825 .

Brouqui P , Amrane S , Million M , Cortaredona S , Parola P , Lagier JC , et al . Asymptomatic hypoxia in COVID-19 is associated with poor outcome . Int J Infect Dis . 2020 ; 102 : 233 - 8 .

Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study . Lancet . 2020 ; 395 ( 10229 ): 1054 - 62 . https://doi.org/10.1016/S0140-6736(20)30566-3 https://doi.org/10.1016/S0140-6736(20)30566-3 .

Tobin MJ , Laghi F , Jubran A . Why COVID-19 silent hypoxemia is baffling to physicians . Am J Respir Crit Care Med . 2020 ; 202 ( 3 ): 356 - 60 . https://doi.org/10.1164/rccm.202006-2157CP https://doi.org/10.1164/rccm.202006-2157CP .

Shah S , Majmudar K , Stein A , Gupta N , Suppes S , Karamanis M , et al . Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization . Acad Emerg Med . 2020 ; 27 ( 8 ): 681 - 92 . https://doi.org/10.1111/acem.14053 https://doi.org/10.1111/acem.14053 .

Gopalakrishnan S , Karmani S , Pandey A , Singh A , Kumar JR , Praveen R , et al . Pulse oximetry screening to detect critical congenital heart diseases in asymptomatic neonates . Med J Armed Forces India . 2020; https://doi.org/10.1016/j.mjafi.2020.09.004 https://doi.org/10.1016/j.mjafi.2020.09.004 .

Bickler PE , Feiner JR , Lipnick MS , McKleroy W . “silent” presentation of hypoxemia and cardiorespiratory compensation in COVID-19 . Anesthesiology . 2021 ; 134 ( 2 ): 262 - 9 . https://doi.org/10.1097/ALN.0000000000003578 https://doi.org/10.1097/ALN.0000000000003578 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Advances in the design and development of SARS-CoV-2 vaccines

A cross-sectional study of olfactory and taste disorders among COVID-19 patients in China

Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China

Development of rapid advice guideline and standard and continuous updating guideline: experiences and practice

A practical approach to imaging characteristics and standardized reporting of COVID-19: A radiologic review